Drug Eluting Stent Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.
CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources
CHAPTER 2. DRUG ELUTING STENT MARKET OVERVIEW
2.1. DRUG ELUTING STENT MARKET INTRODUCTION
2.2. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. Global Drug Eluting Stent Production (VOLUME) and Growth Rate (%), (2017-2025)
2.3. GLOBAL DRUG ELUTING STENT MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. Global Drug Eluting Stent Capacity (VOLUME) and Growth Rate (%), (2017-2025)
2.4. GLOBAL DRUG ELUTING STENT MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1. Global Drug Eluting Stent Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5. GLOBAL DRUG ELUTING STENT MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. Global Drug Eluting Stent Consumption (VOLUME) and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL DRUG ELUTING STENT MARKET BY POLYMER TYPE, 2017-2025
3.1. BIO-ABSORBABLE POLYMER
3.2. DURABLE POLYMER
3.3. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY POLYMER TYPE, 2017-2025
3.3.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Polymer Type, 2017-2025
3.3.2. Bio-absorbable polymer Market Revenue and Growth Rate, 2017-2025
3.3.3. Durable polymer Market Revenue and Growth Rate, 2017-2025
3.4. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION BY POLYMER TYPE, 2017-2025
3.4.1. Global Drug Eluting Stent Market Production (Volume) and Share (%) By Polymer Type, 2017-2025
3.4.2. Bio-absorbable polymer Market Production and Growth Rate, 2017-2025
3.4.3. Durable polymer Market Production and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for material type segment.
CHAPTER 4. GLOBAL DRUG ELUTING STENT MARKET BY APPLICATION, 2017-2025
4.1. CORONARY ARTERY DISEASE
4.2. PERIPHERAL ARTERY DISEASE
4.3. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY APPLICATION, 2017-2025
4.3.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Application, 2017-2025
4.3.2. Coronary artery disease Market Revenue and Growth Rate, 2017-2025
4.3.3. Peripheral artery disease Market Revenue and Growth Rate, 2017-2025
4.4. GLOBAL DRUG ELUTING STENT MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.4.1. Global Drug Eluting Stent Market Consumption (Volume) and share (%) By Application, 2017-2025
4.4.2. Coronary artery disease Market Consumption and Growth Rate, 2017-2025
4.4.3. Peripheral artery disease Market Consumption and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for end user segment.
CHAPTER 5. GLOBAL DRUG ELUTING STENT MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. Canada
5.1.3. Mexico
5.2. EUROPE
5.2.1. U.K.
5.2.2. France
5.2.3. Germany
5.2.4. Italy
5.2.5. Spain
5.2.6. Rest of Europe
5.3. ASIA PACIFIC
5.3.1. China
5.3.2. Japan
5.3.3. India
5.3.4. Korea
5.3.5. Rest of APAC
5.4. SOUTH AMERICA
5.4.1. Brazil
5.4.2. Rest of South America
5.5. REST OF THE WORLD
5.5.1. Middle East
5.5.2. Africa
5.6. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY REGION, 2017-2025
5.6.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Region, 2017-2025
5.6.2. North America Market Revenue and Growth Rate, 2017-2025
5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
5.6.5. South America Market Revenue and Growth Rate, 2017-2025
5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 6. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
6.1. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
6.1.1. Global Drug Eluting Stent Market Production (Volume) and Share (%) By Region, 2017-2025
6.1.2. Global Drug Eluting Stent Market Consumption (Volume) and Share (%) By Region, 2017-2025
6.1.3. North America Market Production and Consumption, 2017-2025
6.1.4. Europe Market Production and Consumption, 2017-2025
6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
6.1.6. South America Market Production and Consumption, 2017-2025
6.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
7.1. MARKET DRIVERS
7.2. MARKET RESTRAINTS
7.3. MARKET OPPORTUNITIES
7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL DRUG ELUTING STENT MARKET COMPETITION BY MANUFACTURERS
8.1. GLOBAL DRUG ELUTING STENT PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
8.1.1. Global Drug Eluting Stent Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
8.2. GLOBAL DRUG ELUTING STENT REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
8.2.1. Global Drug Eluting Stent Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
8.3. DRUG ELUTING STENT MARKET COMPETITIVE SITUATION AND TRENDS
8.3.1. Drug Eluting Stent Market Share (%) of Top 3 Manufacturers
8.3.2. Drug Eluting Stent Market Share (%) of Top 5 Manufacturers
CHAPTER 9. GLOBAL DRUG ELUTING STENT MANUFACTURERS ANALYSIS
9.1. ABBOTT LABORATORIES
9.1.1. Business Overview
9.1.2. Company Basic Information
9.1.3. Drug Eluting Stent Product Details
9.1.4. Abbott Laboratories Drug Eluting Stent Production, Revenue and Gross Margin
9.2. MERIL LIFE SCIENCES PVT.
9.2.1. Business Overview
9.2.2. Company Basic Information
9.2.3. Drug Eluting Stent Product Details
9.2.4. Meril Life Sciences Pvt. Drug Eluting Stent Production, Revenue and Gross Margin
9.3. BOSTON SCIENTIFIC CORPORATION
9.3.1. Business Overview
9.3.2. Company Basic Information
9.3.3. Drug Eluting Stent Product Details
9.3.4. Boston Scientific Corporation Drug Eluting Stent Production, Revenue and Gross Margin
9.4. MEDTRONIC PLC.
9.4.1. Business Overview
9.4.2. Company Basic Information
9.4.3. Drug Eluting Stent Product Details
9.4.4. Medtronic plc. Drug Eluting Stent Production, Revenue and Gross Margin
9.5. BIOSENSORS INTERNATIONAL GROUP, LTD.
9.5.1. Business Overview
9.5.2. Company Basic Information
9.5.3. Drug Eluting Stent Product Details
9.5.4. Biosensors International Group, Ltd. Drug Eluting Stent Production, Revenue and Gross Margin
9.6. BIOTRONIK SE & CO. KG
9.6.1. Business Overview
9.6.2. Company Basic Information
9.6.3. Drug Eluting Stent Product Details
9.6.4. BIOTRONIK SE & Co. KG Drug Eluting Stent Production, Revenue and Gross Margin
9.7. B. BRAUN MELSUNGEN AG
9.7.1. Business Overview
9.7.2. Company Basic Information
9.7.3. Drug Eluting Stent Product Details
9.7.4. B. Braun Melsungen AG Drug Eluting Stent Production, Revenue and Gross Margin
9.8. MICROPORT SCIENTIFIC CORPORATION, LTD.
9.8.1. Business Overview
9.8.2. Company Basic Information
9.8.3. Drug Eluting Stent Product Details
9.8.4. MicroPort Scientific Corporation, Ltd. Drug Eluting Stent Production, Revenue and Gross Margin
9.9. TERUMO CORPORATION
9.9.1. Business Overview
9.9.2. Company Basic Information
9.9.3. Drug Eluting Stent Product Details
9.9.4. TERUMO CORPORATION Drug Eluting Stent Production, Revenue and Gross Margin
9.10. TRANSLUMINA GMBH
9.10.1. Business Overview
9.10.2. Company Basic Information
9.10.3. Drug Eluting Stent Product Details
9.10.4. Translumina GmbH Drug Eluting Stent Production, Revenue and Gross Margin
CHAPTER 10. DRUG ELUTING STENT MARKET VALUE CHAIN ANALYSIS
10.1. DRUG ELUTING STENT INDUSTRIAL CHAIN ANALYSIS
10.2. DRUG ELUTING STENT KEY RAW MATERIALS ANALYSIS
10.2.1. Key Raw Materials
10.2.2. Price Trend of Key Raw Materials
10.2.3. Key Suppliers of Raw Materials
10.3. CONSUMER ANALYSIS
10.3.1. Consumer 1
10.3.2. Consumer 2
10.3.3. Consumer 3
10.3.4. Consumer 4